Cancer of the Prostate: Molecular Genetics
211
carcinoma in the Utah Mormon genealogy,
Cancer Surv.
1
, 48–69.
Carpten, J., Nupponen, N., Isaacs, S., Sood, R.,
Robbins, C., Xu, J., Faruque, M., Moses, T.,
Ewing, C.,
Gillanders, E.,
Hu, P.,
Bu-
jnovszky, P., Makalowska, I., Baffoe-Bonnie,
A.,Faith,D.,Smith,J.,Stephan,D.,Wiley,K.,
Brownstein, M., Gildea, D., Kelly, B., Jenk-
ins, R., Hostetter, G., Matikainen, M., Schleut-
ker, J.,
Klinger, K.,
Connors, T.,
Xiang, Y.,
Wang, Z., De Marzo, A., Papadopoulos, N.,
Kallioniemi, O.P., Burk, R., Meyers, D., Gron-
berg, H., Meltzer, P., Silverman, R., Bailey-
Wilson, J.,
Walsh, P.,
Isaacs, W.,
Trent, J.
(2002) Germline mutations in the ribonucle-
ase L gene in families showing linkage with
HPC1,
Nat. Genet.
30
(2), 181–184.
Carruba, G.,
Miceli, D.,
D’Amico, D.,
et al.
(1995) Sex steroids up-regulate E-cadherin
expression
in
hormone-responsive
LNCaP
human prostate cancer cells,
Biochem. Biophys.
Res. Commun.
212
, 624–631.
Carter, B.S., Beaty, T.H., Steinberg, G.D., et al.
(1992)
Mendelian
inheritance
of
familial
prostate cancer,
Proc. Natl. Acad. Sci. U.S.A.
89
, 3367–3371.
Carter, B.S., Bova, G.S., Beaty, T.H., et al. (1993)
Hereditary prostate cancer: epidemiologic and
clinical features,
J. Urol.
150
, 797–802.
Carter, B.S., Epstein, J.I., Isaacs, W.B. (1990) Ras
gene mutations in human prostate carcinoma,
Cancer Res.
50
, 6830–6832.
Castagnaro, M.,
Yandell, D.W.,
Dockhorn-
Dworniczak, B.,
et al.
(1993)
Androgen
receptor gene mutations and p53 gene analysis
in advanced prostate cancer,
Verh. Dtsch. Ges.
Pathol.
77
, 119–123.
Chan, J.M.,
Stampfer, M.J.,
Giovannucci, E.,
et al. (1998) Plasma insulinlike growth factor-I
and prostate cancer risk: a prospective study,
Science
279
, 563–566.
Chen, C., Bhalala, H.V., Vessella, R.L., Dong,
J.T. (2003) KLF5 is frequently deleted and
down-regulated but rarely mutated in prostate
cancer,
Prostate
55
(2), 81–88.
Chen, W.C., Obrink, B. (1991) Cell-cell contacts
mediated by E-cadherin (uvomorulin) restrict
invasive behavior of L-cells,
J. Cell Biol.
114
,
319–327.
Cheng, K.D., Loeb, L.A. (1993) Genomic insta-
bility and tumor progression: mechanistic
considerations,
Adv. Cancer Res.
60
, 121–156.
Cheng, L., Nagabhushan, M., Pretlow, T.P., et al.
(1996) Expression of E-cadherin in primary
and metastatic prostate cancer,
Am
.J
.Pa
tho
l
.
148
, 1375–1380.
Cher, M.L., Bova, G.S., Moore, D.H., et al. (1996)
Genetic alterations in untreated metastases
and androgen-independent prostate cancer de-
tected by comparative genomic hybridization
and allelotyping,
Cancer Res.
56
, 3091–3102.
Cher, M.L., MacGrogan, D., Bookstein, R., et al.
(1994) Comparative genomic hybridization,
allelic imbalance, and fluorescence in situ
hybridization on chromosome 8 in prostate
cancer,
Genes
Chromosomes
Cancer
11
,
153–162.
Ching, K.Z.,
Ramsey, E.,
Pettigrew, N.,
et al.
(1993) Expression of mRNA for epidermal
growth factor, transforming growth factor-
alpha and their receptor in human prostate
tissue and cell lines,
Mol. Cell. Biochem.
126
,
151–158.
Cress, A.E.,
Rabinovitz, I.,
Zhu, W.G.,
Na-
gle, R.B. (1995) The alpha-6-beta-1 and alpha-
6-beta-4 integrins in human prostate can-
cer progression,
Cancer Metastasis Rev.
14
,
219–228.
Crundwell, M.C.,
Morton, D.G.,
Arkell, D.G.,
Phillips, S.M. (1999) Genetic instability in
incidentally discovered and advanced prostate
cancer,
BJU Int.
84
, 123–127.
Cunningham, J.M., Shan, A., Wick, M.J., et al.
(1996) Allelic imbalance and microsatellite
instability in prostatic adenocarcinoma,
Cancer
Res.
56
, 4475–4482.
Dahiya, R., Deng, G., Chen, K.M., et al. (1996)
P53 tumor-suppressor gene mutations are
mainly localised on exon 7 in human primary
and metastatic prostate cancer,
B
r
.J
.Can
c
e
r
74
, 264–268.
Dahiya, R., Lee, C., McCarville, J., et al. (1997)
High
frequency
of
genetic
instability
of
microsatellites in prostatic adenocarcinoma,
Int. J. Cancer
72
, 762–767.
Davis, D.L., Russell, D.W. (1993) Unusual length
polymorphism in human steroid 5 alpha-
reductase type 2 gene (SRD5A2),
Hum. Mol.
Genet.
2
, 820.
DeLange, T. (1994) Activation of telomerase in a
human tumor,
Proc. Natl. Acad. Sci. U.S.A.
91
,
2882–2885.
Deocampo, N.D., Huang, H., Tindall, D.J. (2003)
The role of PTEN in the progression and
survival of prostate cancer,
Minerva Endocrinol.
28
(2), 145–153.
